Are capecitabine and oxaliplatin (XELOX) suitable treatments for progressing low-grade and high-grade neuroendocrine tumours?

Emilio Bajetta,Laura Catena,Giuseppe Procopio,Sara De Dosso,Ettore Bichisao,Leonardo Ferrari,Antonia Martinetti,Marco Platania,Elena Verzoni,Barbara Formisano,Roberto Bajetta

Are capecitabine and oxaliplatin (XELOX) suitable treatments for progressing low-grade and high-grade neuroendocrine tumours?

2007

Emilio Bajetta
Laura Catena
Giuseppe Procopio
Sara De Dosso
Ettore Bichisao
Leonardo Ferrari
Antonia Martinetti
Marco Platania
Elena Verzoni
Barbara Formisano
Roberto Bajetta

Purpose The aim of this trial was to evaluate the safety and efficacy of oxaliplatin and capecitabine (XELOX) in neuroendocrine tumours’ (NETs) treatment.

Keywords:

Oncology
Capecitabine
Oxaliplatino
Pharmacology
Capecitabina
Oxaliplatin
Chemotherapy
Surgery
Internal medicine
Medicine
pharmacology toxicology

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

184

Citations